Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

TFX

TELEFLEX INC

Healthcare · Surgical & Medical Instruments & Apparatus

$127.38Sep 28, 2026

AI confidence 20% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

TELEFLEX INC shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +29% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +29% YoY in Q2 FY2026

Pipeline evidence · 0d ago

TFX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on TFX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full TFX earnings analysis

Reported figures for TELEFLEX INC — research only, not investment advice.

Revenue YoY
+28.9%
EPS YoY
-17.7%

Latest Intelligence

Updated

What happened recently for TELEFLEX INC (TFX) — events, not interpretation.

Event
Reported Q2 2026 revenue +29% YoY.
Also
Last session September 28, 2026 at $127.38.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

TELEFLEX INC (TFX)

Healthcare · Surgical & Medical Instruments & Apparatus

Investment Snapshot above is the primary AlphaOS analysis for TELEFLEX INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$5.40B
Revenue:
$1.99B

TFX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow TELEFLEX INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.

Structured stock intelligence for companies connected to this research.